Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;190(1):e16-e20.
doi: 10.1111/bjh.16801. Epub 2020 May 27.

Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies

Fernando Martín-Moro  1 , Juan Marquet  1 , Miguel Piris  1 , Berta M Michael  1 , Adolfo J Sáez  1 , Magdalena Corona  1 , Carlos Jiménez  1 , Beatriz Astibia  1 , Irene García  1 , Eulalia Rodríguez  2 , Carlota García-Hoz  2 , Jesús Fortún-Abete  3 , Pilar Herrera  1 , Javier López-Jiménez  1
Affiliations

Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies

Fernando Martín-Moro et al. Br J Haematol. 2020 Jul.
No abstract available

Keywords: acute respiratory distress syndrome; complete remission; coronavirus disease; haematological malignancies; interlerleukin 6.

PubMed Disclaimer

Conflict of interest statement

All authors declare no conflicts of interest.

Figures

Fig 1
Fig 1
Overall survival according to haematologic malignancy diagnosis previous to SARS‐CoV‐2 infection. (A) Overall survival according to haematologic treatment purpose at the time of illness onset, excluded five cases on life support. (B) Overall survival depending on qSOFA, CURB‐65 and ECOG PS at first hospital admission or at COVID‐19 onset. (C) Overall survival according to the development of moderate or severe ARDS during hospitalisation period.
See this image and copyright information in PMC

References

    1. Desai A, Sachdeva S, Parekh T, Desai R. COVID‐19 and cancer: lessons from a pooled meta‐analysis. JCO Global Oncol. 2020;6:557–9. - PMC - PubMed
    1. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS‐CoV‐2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335–7. - PMC - PubMed
    1. He W, Chen L, Chen L, Yuan G, Fang Y, Chen W, et al. COVID‐19 in persons with haematological cancers. Leukemia. 2020;10.1038/s41375-020-0836-7. - DOI - PMC - PubMed
    1. Willan J, King AJ, Hayes S, Collins GP, Peniket A. Care of haematology patients in a COVID‐19 epidemic. Br J Haematol. 2020;189:241–3. - PMC - PubMed
    1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395: 1054–62.10.1016/s0140-6736(20)30566-3. - DOI - PMC - PubMed

MeSH terms